717 results on '"Woodle, E Steve"'
Search Results
2. Long-term Safety in Epstein–Barr Virus–Seropositive Kidney-only Transplant Recipients Treated With Belatacept in Clinical Practice: Final Study Results From the ENLiST Registry
3. Precision Medicine in Nephrology: An Integrative Framework of Multidimensional Data in the Kidney Precision Medicine Project
4. Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
5. Effects of invivo CXCR4 blockade and proteasome inhibition on bone marrow plasma cells in HLA-sensitized kidney transplant candidates
6. Molecular Signatures of Glomerular Neovascularization in a Patient with Diabetic Kidney Disease
7. Participant Experience with Protocol Research Kidney Biopsies in the Kidney Precision Medicine Project
8. Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti-CD20 monoclonal antibody for the desensitization of candidates for renal transplant
9. The immune cell landscape in kidneys of patients with lupus nephritis
10. Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.
11. One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial
12. Cadherin-11, Sparc-related modular calcium binding protein-2, and Pigment epithelium-derived factor are promising non-invasive biomarkers of kidney fibrosis
13. Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients
14. Obinutuzumab Effectively Depletes Key B-cell Subsets in Blood and Tissue in End-stage Renal Disease Patients
15. Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement
16. Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement
17. Plasma cell targeting to prevent antibody-mediated rejection
18. Cost-effectiveness of Using Kidneys From HCV-Viremic Donors for Transplantation Into HCV-Uninfected Recipients
19. Belatacept-based immunosuppression with simultaneous calcineurin inhibitor avoidance and early corticosteroid withdrawal: A prospective, randomized multicenter trial
20. Proteasomal adaptations underlying carfilzomib-resistance in human bone marrow plasma cells
21. A prospective, iterative, adaptive trial of carfilzomib-based desensitization
22. Long-term outcomes in patients with obesity and renal disease after sleeve gastrectomy
23. Rabbit anti-thymocyte globulin for the prevention of acute rejection in kidney transplantation
24. Assessment of tacrolimus intrapatient variability in stable adherent transplant recipients: Establishing baseline values
25. Impact of Induction Therapy on Circulating T Follicular Helper Cells and Subsequent Donor-Specific Antibody Formation After Kidney Transplant
26. Defining the T cell transcriptional landscape in pediatric liver transplant rejection at single cell resolution
27. Prior viral infection primes cross-reactive CD8+ T cells that respond to mouse heart allografts
28. Development and Validation of a Multiplex, Bead-Based Assay to Detect Antibodies Directed Against SARS-CoV-2 Proteins
29. Immunosuppression for Liver Retransplantation: Babel Revisited
30. High-Dimensional Renal Profiling: Towards a Better Understanding of Renal Transplant Immune Suppression
31. The Proteasome Inhibitor Bortezomib Induces p53-Dependent Apoptosis in Activated B Cells
32. Addressing the challenges of sleeve gastrectomy in end-stage renal disease: Analysis of 100 consecutive renal failure patients
33. mTOR Inhibitor Therapy Diminishes Circulating CD8+ CD28− Effector Memory T Cells and Improves Allograft Inflammation in Belatacept-refractory Renal Allograft Rejection
34. Reducing Donor Specific Antibody During Acute Rejection Diminishes Long Term Renal Allograft Loss: Comparison of Early and Late Rejection
35. Single cell transcriptomic analysis of renal allograft rejection reveals insights into intragraft TCR clonality
36. Carfilzomib‐based antibody mediated rejection therapy in pediatric kidney transplant recipients
37. Effects of In Vivo CXCR4 Blockade and Proteasome Inhibition on Bone Marrow Plasma Cells in HLA-Sensitized Kidney Transplant Candidates
38. Hospital Resource Use with Donation after Cardiac Death Allografts in Liver Transplantation: A Matched Controlled Analysis from 2007 to 2011
39. Independent effect of black recipient race on short-term outcomes after liver transplantation
40. Single cell transcriptomic analysis of renal allograft rejection reveals novel insights into intragraft TCR clonality
41. Is liver transplantation safe and effective in elderly (≥70 years) recipients? A case-controlled analysis
42. Neighborhood Level Effects of Socioeconomic Status on Liver Transplant Selection and Recipient Survival
43. Increasing prevalence of nonalcoholic steatohepatitis as an indication for liver transplantation
44. Hospital utilization and consequences of readmissions after liver transplantation
45. Management of Antibody-Mediated Rejection in Transplantation
46. The Role of Immunosuppression in Lymphoma
47. Integrated single-cell sequencing and histopathological analyses reveal diverse injury and repair responses in a participant with acute kidney injury: a clinical-molecular-pathologic correlation
48. Proteasome Inhibition for Antibody-Mediated Allograft Rejection
49. Targeting the Ubiquitin+Proteasome System in Solid Tumors
50. Publisher Correction: The immune cell landscape in kidneys of patients with lupus nephritis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.